Jaco Botha

Director, Global Medical Affairs Group Lead
Takeda Pharmaceuticals International AG

Presentation(s):

• PB0673 - A Post-authorization Safety Surveillance Study To Report Clinical Experience With Purified FIX Concentrate in Pediatric Patients With Hemophilia B

  Monday, July 11, 2022
  6:30 PM – 7:30 PM